BackSofiva Genomics ,Ltd. Overview

Sofiva Genomics ,Ltd. Accounts Payable

Sofiva Genomics ,Ltd.'s accounts payable is $18M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$17.91M
↓ 24.28% YoYΔ $-5.75M vs prior year quarter

Peer trimmed avg / median

Loading

Sofiva Genomics ,Ltd. Accounts Payable History

Loading

Sofiva Genomics ,Ltd. vs. peers: Accounts Payable Comparison

Loading

Sofiva Genomics ,Ltd. Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sofiva Genomics ,Ltd. (6615.TWO) FAQ

The latest accounts payable for 6615.TWO is $18M as of June 2026. That compares with $24M in the prior-year period — down 24.3% year over year. Investors often review this figure alongside Sofiva Genomics ,Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 6615.TWO's accounts payable moved from $24M to $18M — a 24.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sofiva Genomics ,Ltd.'s operating scale or balance-sheet position.

A accounts payable figure of $18M for 6615.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 6615.TWO's accounts payable ($18M), review year-over-year change from $24M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.